Cholangiocarcinomas (CCAs) are diverse
biliary epithelial tumours involving the
intrahepatic, perihilar and distal parts
of the biliary tree. Each anatomical
subtype has distinct epidemiology,
molecular characteristics, prognosis
and strategy for clinical management¹